A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease


YILMAZ Y., EREN F.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, vol.26, no.11, pp.1292-1295, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 11
  • Publication Date: 2014
  • Doi Number: 10.1097/meg.0000000000000184
  • Journal Name: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1292-1295
  • Keywords: Bayes' theorem, Fibroscan, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, noninvasive diagnosis, METABOLIC SYNDROME, NATURAL-HISTORY, BIOMARKER PANEL, FIBROSIS, EPIDEMIOLOGY, STEATOSIS, BIOPSY, CANCER, TESTS, NAFLD
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Background The distinction between definitive nonalcoholic steatohepatitis (NASH) and other histological patterns of nonalcoholic fatty liver disease (NAFLD) continues to rely on liver biopsy, which has risks and limitations.